These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

745 related items for PubMed ID: 23470647

  • 1. Isoniazid- and streptomycin-resistant miliary tuberculosis complicated by intracranial tuberculoma in a Japanese infant.
    Ishiwada N, Tokunaga O, Nagasawa K, Ichimoto K, Kinoshita K, Hishiki H, Kohno Y.
    Tohoku J Exp Med; 2013 Mar; 229(3):221-5. PubMed ID: 23470647
    [Abstract] [Full Text] [Related]

  • 2. [Aseptic cerebral venous thrombosis and multiple cerebral tuberculomas associated with pulmonary miliary tuberculosis].
    Messouak O, Amara B, Benjelloun FZ, Tizniti S, Benjelloun MC, Belahsen MF.
    Rev Neurol (Paris); 2007 Feb; 163(2):238-40. PubMed ID: 17351544
    [Abstract] [Full Text] [Related]

  • 3. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.
    Monaldi Arch Chest Dis; 1994 Sep; 49(4):327-45. PubMed ID: 8000420
    [Abstract] [Full Text] [Related]

  • 4. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 5. [Management and treatment difficulties of multi-drug resistant pulmonary tuberculosis in a pediatric case].
    Hançerli Törün S, Acar EM, Somer A, Erköse G, Şatana D, Bayramoğlu Z, Çalışkan E, Kılıçaslan Z.
    Mikrobiyol Bul; 2018 Jan; 52(1):89-95. PubMed ID: 29642833
    [Abstract] [Full Text] [Related]

  • 6. Central nervous system tuberculosis after resolution of miliary tuberculosis.
    Chang AB, Grimwood K, Harvey AS, Rosenfeld JV, Olinsky A.
    Pediatr Infect Dis J; 1998 Jun; 17(6):519-23. PubMed ID: 9655548
    [No Abstract] [Full Text] [Related]

  • 7. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 8. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 9. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M.
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [Abstract] [Full Text] [Related]

  • 10. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
    Khan MY, Kinsara AJ, Osoba AO, Wali S, Samman Y, Memish Z.
    Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231
    [Abstract] [Full Text] [Related]

  • 11. [Intracranial tuberculomas developing during treatment of pulmonary tuberculosis: case report].
    Pimentel ML, Alves SM, Novis SA, Brandão RZ, Belo Neto E.
    Arq Neuropsiquiatr; 2000 Jun; 58(2B):572-7. PubMed ID: 10920425
    [Abstract] [Full Text] [Related]

  • 12. Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009.
    Gegia M, Cohen T, Kalandadze I, Vashakidze L, Furin J.
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):812-6. PubMed ID: 22507372
    [Abstract] [Full Text] [Related]

  • 13. Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues.
    Skevaki CL, Kafetzis DA.
    Paediatr Drugs; 2005 Jun; 7(4):219-34. PubMed ID: 16117559
    [Abstract] [Full Text] [Related]

  • 14. Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
    Somner AR, Selkon JB, Walton M, White AB.
    Tubercle; 1971 Dec; 52(4):266-75. PubMed ID: 5143922
    [No Abstract] [Full Text] [Related]

  • 15. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C, Vargas MH, Martínez-Rossier LA, Torres-Cruz A, Villarreal-Velarde H.
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of tuberculosis].
    Ben Amar J, Dhahri B, Aouina H, Azzabi S, Baccar MA, El Gharbi L, Bouacha H.
    Rev Pneumol Clin; 2015 Mar; 71(2-3):122-9. PubMed ID: 25434510
    [Abstract] [Full Text] [Related]

  • 18. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y, Nagayama N, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Komatsu H, Yotsumoto H.
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [Abstract] [Full Text] [Related]

  • 19. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [Abstract] [Full Text] [Related]

  • 20. A Clinical Study of Miliary Brain Tuberculomas in China.
    Yang M, Zhang JT, Yao Y, Tan QC, Gao T, Tian CL, Huang X, Yu SY.
    Jpn J Infect Dis; 2016 May 20; 69(3):231-5. PubMed ID: 26255731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.